EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS69 - Allied health and primary care

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
D3.394
Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
D3.397
China's Hypoallergenic Home Visit Program: A Standardized Process for Environmental Control Based on a Mobile Application
D3.393
Daily life with a peanut allergy, as a young adult- an interview study
D3.389
Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
D3.395
Evaluation for suspected penicillin allergy - the patient perspective
D3.396
Evidence summary of indoor environmental controls in dust mite allergic patients
D3.398
Food provision experience of inpatients with adverse food reactions in the acute hospital setting
D3.390
Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391
Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.392
What information and education is crucial for people with food allergies?

Chairs

Speakers